Reality bites the leftist media with shakeups, layoffs amid decline
If the state of the legacy media as 2025 begins were put to music, the only appropriate soundtrack would be the iconic theme ...
Le Lézard15 分钟
Incyte and Syndax Announce U.S. Food and Drug Administration (FDA) Approval of Niktimvotm ...
Niktimvo (axatilimab-csfr) is a first-in-class colony stimulating factor-1 receptor (CSF-1R)-blocking antibody approved for use in the U.S. for the treatment of chronic graft-versus-host disease (GVHD ...